LONDON, ONTARIO--(Marketwire - June 09, 2008) - Stellar Pharmaceuticals Inc. (“Stellar” or the “Company”) (TSX VENTURE: SLX)(OTCBB: SLXCF) Stellar announced today that it has received approval from the TSX Venture Exchange for the voluntary delisting of its Common Shares from the facilities of the Exchange. The delisting will become effective on June 16, 2008. Stellar’s Common Shares will continue to trade on the OTCBB under the symbol SLXCF.OB.
